Key result
Pediatric VAD-supported patients presenting to the ED had lower admission or transfer rates compared to young adults (37.8% vs. 57.8%, p<0.05), with admissions driven primarily by high acuity diagnoses.
Why the study?
Data describing outcomes in ambulatory pediatric and young adult ventricular assist device-supported patient populations were minimal.
Does age impact emergency resource utilization and outcomes in pediatric and young adult patients supported with a ventricular assist device?
Observational (n=2,568)
Yes
Does age impact emergency resource utilization and outcomes in pediatric and young adult patients supported with a ventricular assist device?
Absolute Event Rate: 37.8% vs 57.8%
p-value: p=<0.05
In pediatric and young adult VAD patients presenting to the ED, clinical outcomes and admission rates are driven by high acuity presentations and comorbidities rather than age itself.
May support age-specific ED triage for pediatric VAD patients; hypothesis-generating and should not yet change practice.
There are minimal data describing outcomes in ambulatory pediatric and young adult ventricular assist device (VAD)-supported patient populations. We performed a retrospective analysis of encounter-level data from 2006 to 2017 Nationwide Emergency Department Sample (NEDS) to compare emergency department (ED) resource utilization and outcomes for pediatric (≤18 years, n = 494) to young adult (19-29 years, n = 2,074) VAD-supported patient encounters. Pediatric encounters were more likely to have a history of congenital heart disease (11.3% vs. 4.8%). However, Pediatric encounters had lower admission/transfer rates (37.8% vs. 57.8%) and median charges ($3,334 (IQR $1,473-$19,818) vs. $13,673 ($3,331-$45,884)) (all p < 0.05). Multivariable logistic regression modeling revealed that age itself was not a predictor of admission, instead high acuity primary diagnoses and medical complexity were: (adjusted odds ratio; 95% confidence intervals): cardiac (3.0; 1.6-5.4), infection (3.4; 1.7-6.5), bleeding (3.9; 1.7-8.8), device complication (7.2; 2.7-18.9), and ≥1 chronic comorbidity (4.1; 2.5-6.7). In this largest study to date describing ED resource use and outcomes for pediatric and young adult VAD-supported patients, we found that, rather than age, high acuity presentations and comorbidities were primary drivers of clinical outcomes. Thus, reducing morbidity in this population should target comorbidities and early recognition of VAD-related complications.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2021) conducted an observational in Ventricular assist device (VAD) support (n=2,568). Pediatric age (≤18 years) vs. Young adult age (19-29 years) was evaluated on Admission/transfer rates (p=<0.05). Pediatric VAD-supported patients presenting to the ED had lower admission or transfer rates compared to young adults (37.8% vs. 57.8%, p<0.05), with admissions driven primarily by high acuity diagnoses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: